We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$19.2B
AUM Growth
+$2.52B
Cap. Flow
+$1.25B
Cap. Flow %
6.54%
Top 10 Hldgs %
17.34%
Holding
2,313
New
197
Increased
1,021
Reduced
855
Closed
212

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 15.67%
3 Healthcare 9.34%
4 Consumer Discretionary 9.15%
5 Real Estate 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
251
Boston Scientific
BSX
$71.5B
$16.9M 0.09%
397,373
-22,837
-5% -$960K
VLO icon
252
Valero Energy
VLO
$85.9B
$16.8M 0.09%
224,089
-6,910
-3% -$515K
AKR icon
253
Acadia Realty Trust
AKR
$2.84B
$16.7M 0.09%
762,871
+55,347
+8% +$1.21M
CAT icon
254
Caterpillar
CAT
$387B
$16.6M 0.09%
80,329
-5,966
-7% -$1.2M
RRC icon
255
Range Resources
RRC
$8.95B
$16.6M 0.09%
929,069
-44,431
-5% -$958K
KEY icon
256
KeyCorp
KEY
$24.4B
$16.4M 0.09%
708,580
+9,615
+1% +$223K
DHI icon
257
D.R. Horton
DHI
$42.3B
$16.4M 0.09%
150,888
-9,885
-6% -$952K
AZN icon
258
AstraZeneca
AZN
$250B
$16.2M 0.08%
139,304
-33,582
-19% -$3.95M
PPL
259
PPL Corp
PPL
$26.7B
$16.2M 0.08%
538,593
+28,957
+6% +$836K
GWW icon
260
W.W. Grainger
GWW
$60.2B
$16M 0.08%
30,939
-2,962
-9% -$1.4M
AVK
261
Advent Convertible and Income Fund
AVK
$563M
$16M 0.08%
890,078
+45,272
+5% +$819K
SYY icon
262
Sysco
SYY
$40.3B
$15.9M 0.08%
202,842
+11,091
+6% +$854K
OKE icon
263
Oneok
OKE
$54.5B
$15.9M 0.08%
271,064
-521
-0.2% -$32.3K
LYB icon
264
LyondellBasell Industries
LYB
$19.2B
$15.8M 0.08%
171,382
+52,613
+44% +$4.88M
HYD icon
265
VanEck High Yield Muni ETF
HYD
$4.45B
$15.7M 0.08%
250,829
+8,933
+4% +$556K
BDJ icon
266
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
$15.6M 0.08%
1,548,217
+120,528
+8% +$1.21M
DD icon
267
DuPont de Nemours
DD
$19.2B
$15.6M 0.08%
153,554
-16,353
-10% -$1.56M
RHP icon
268
Ryman Hospitality Properties
RHP
$7.63B
$15.5M 0.08%
168,640
+34,226
+25% +$2.94M
AOS icon
269
A.O. Smith
AOS
$8.7B
$15.5M 0.08%
180,278
-45,858
-20% -$3.5M
CLX icon
270
Clorox
CLX
$12.7B
$15.5M 0.08%
88,658
-28,186
-24% -$4.7M
LCID icon
271
Lucid Motors
LCID
$2.77B
$15.5M 0.08%
40,622
+36,738
+946% +$13.8M
IGSB icon
272
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$15.4M 0.08%
286,258
-22,759
-7% -$1.23M
CCI icon
273
Crown Castle
CCI
$32.2B
$15.4M 0.08%
73,858
+9,897
+15% +$1.83M
MAR icon
274
Marriott International
MAR
$92.3B
$15.4M 0.08%
93,279
+8,290
+10% +$1.3M
AMCR icon
275
Amcor
AMCR
$22.1B
$15.4M 0.08%
256,121
+33,512
+15% +$1.99M

Similar funds

Guggenheim Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Guggenheim Capital held 2,313 positions worth $19.2B, up 15% from $16.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital deployed $1.25B of net new capital in Q4 2021, opening 197 new positions and adding to 1,021 existing holdings. Its largest new stake was AfterNext HealthTech Acquisition Corp: 3,725,000 shares worth $36.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Tesla, an estimated $28.7M trimmed.

  • Guggenheim Capital's largest Q4 2021 buy was AfterNext HealthTech Acquisition Corp: 3,725,000 shares worth $36.3M.
  • Guggenheim Capital added most to FIGS in Q4 2021, an estimated $173M increase.
  • Guggenheim Capital's biggest Q4 2021 reduction was Tesla, cutting an estimated $28.7M.
  • Guggenheim Capital fully exited AfterNext HealthTech Acquisition Corp Units in Q4 2021, selling an estimated $37.1M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $19.2B portfolio in Q4 2021.
  • Guggenheim Capital opened 197 new positions and closed 212 in Q4 2021.
  • Guggenheim Capital's portfolio value rose 15% quarter-over-quarter to $19.2B.

Based on Guggenheim Capital's 13F filing for Q4 2021, filed 14 Feb 2022.